Allopurinol in the treatment of acquired reactive perforating collagenosis()

Acquired reactive perforating collagenosis is a perforating dermatosis usually associated with different systemic diseases, mainly diabetes mellitus and/or chronic renal insufficiency. Different therapies have been tried but treatment is not standardized yet and remains a challenge. In the last few...

Descripción completa

Detalles Bibliográficos
Autores principales: Tilz, Hemma, Becker, Jürgen Christian, Legat, Franz, Schettini, Antonio Pedro Mendes, Inzinger, Martin, Massone, Cesare
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Sociedade Brasileira de Dermatologia 2013
Materias:
Case Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3699945/
https://www.ncbi.nlm.nih.gov/pubmed/23539010
http://dx.doi.org/10.1590/S0365-05962013000100012
_version_ 1782275470416412672
author Tilz, Hemma
Becker, Jürgen Christian
Legat, Franz
Schettini, Antonio Pedro Mendes
Inzinger, Martin
Massone, Cesare
author_facet Tilz, Hemma
Becker, Jürgen Christian
Legat, Franz
Schettini, Antonio Pedro Mendes
Inzinger, Martin
Massone, Cesare
author_sort Tilz, Hemma
collection PubMed
description Acquired reactive perforating collagenosis is a perforating dermatosis usually associated with different systemic diseases, mainly diabetes mellitus and/or chronic renal insufficiency. Different therapies have been tried but treatment is not standardized yet and remains a challenge. In the last few years, allopurinol has been reported as a good therapeutic option for acquired reactive perforating collagenosis. We describe the case of a 73-year-old man affected by acquired reactive perforating collagenosis associated with diabetes type 1 and chronic renal failure with secondary hyperparathyroidism. The patient was successfully treated with allopurinol 100mg once/day p.o..
format Online
Article
Text
id pubmed-3699945
institution National Center for Biotechnology Information
language English
publishDate 2013
publisher Sociedade Brasileira de Dermatologia
record_format MEDLINE/PubMed
spelling pubmed-36999452013-07-09 Allopurinol in the treatment of acquired reactive perforating collagenosis() Tilz, Hemma Becker, Jürgen Christian Legat, Franz Schettini, Antonio Pedro Mendes Inzinger, Martin Massone, Cesare An Bras Dermatol Case Report Acquired reactive perforating collagenosis is a perforating dermatosis usually associated with different systemic diseases, mainly diabetes mellitus and/or chronic renal insufficiency. Different therapies have been tried but treatment is not standardized yet and remains a challenge. In the last few years, allopurinol has been reported as a good therapeutic option for acquired reactive perforating collagenosis. We describe the case of a 73-year-old man affected by acquired reactive perforating collagenosis associated with diabetes type 1 and chronic renal failure with secondary hyperparathyroidism. The patient was successfully treated with allopurinol 100mg once/day p.o.. Sociedade Brasileira de Dermatologia 2013 /pmc/articles/PMC3699945/ /pubmed/23539010 http://dx.doi.org/10.1590/S0365-05962013000100012 Text en ©2013 by Anais Brasileiros de Dermatologia http://creativecommons.org/licenses/by-nc/3.0/ This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License, which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Case Report
Tilz, Hemma
Becker, Jürgen Christian
Legat, Franz
Schettini, Antonio Pedro Mendes
Inzinger, Martin
Massone, Cesare
Allopurinol in the treatment of acquired reactive perforating collagenosis()
title Allopurinol in the treatment of acquired reactive perforating collagenosis()
title_full Allopurinol in the treatment of acquired reactive perforating collagenosis()
title_fullStr Allopurinol in the treatment of acquired reactive perforating collagenosis()
title_full_unstemmed Allopurinol in the treatment of acquired reactive perforating collagenosis()
title_short Allopurinol in the treatment of acquired reactive perforating collagenosis()
title_sort allopurinol in the treatment of acquired reactive perforating collagenosis()
topic Case Report
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3699945/
https://www.ncbi.nlm.nih.gov/pubmed/23539010
http://dx.doi.org/10.1590/S0365-05962013000100012
work_keys_str_mv AT tilzhemma allopurinolinthetreatmentofacquiredreactiveperforatingcollagenosis
AT beckerjurgenchristian allopurinolinthetreatmentofacquiredreactiveperforatingcollagenosis
AT legatfranz allopurinolinthetreatmentofacquiredreactiveperforatingcollagenosis
AT schettiniantoniopedromendes allopurinolinthetreatmentofacquiredreactiveperforatingcollagenosis
AT inzingermartin allopurinolinthetreatmentofacquiredreactiveperforatingcollagenosis
AT massonecesare allopurinolinthetreatmentofacquiredreactiveperforatingcollagenosis

Ejemplares similares